Cite Filings / ENGN / 0001193125-26-059479

Feed Companies Filings Check

Sign in

S-3

Registration Statement

enGene Therapeutics Inc. Filed 2026-02-19 Acc 0001193125-26-059479

Documents 1

S-3 Registration Statement , engn-20260219.htm

Around this filing

2026-02-25 UPLOAD SEC-generated Letter
2026-02-19 S-3 Registration Statement
2026-02-19 10-K/A 10-K/A
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership
2024-11-13 S-3 Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading engn-20260219.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…